Our long-term objective is to understand the molecular events that underlie the induction of differentiation in ML-1 human myeloblastic leukemia cells. We have identified a gene that increases in expression early in induction with 12-0-tetradecanoylphorbol-13-acetate (TPA). We have designated this gene mcl-1, based on its isolation from maturing myeloid ML-1 cell leukemia. The increase in mcl-1 mRNA occurs within one to three hours, preceding maturation to monocyte/macrophages at one to three days. We found mcl-1 to exhibit significant homology to bcl-2, a gene that plays an as-yet poorly understood role in t(14;18)B-cell lymphomas. mcl-1 is the first example of a cellular gene with significant homology to bcl-2. We now propose to study the mcl-1-encoded protein, exploring its possible site(s) of action and role(s) in cell proliferation, differentiation, and viability. We will study the behavior of the mcl-1 protein in cell-free systems (Aim I), determining whether it is processed by microsomal membranes (via its putative signal sequence) or might associate with isolated mitochondria (via the potential membrane spanning region with homology to bcl-2). We will prepare monoclonal and polyclonal antibodies (Aim II) for use in studying the mcl-1 protein in intact cells (Aim III): Using results from Aim I as a guide, we will assess the intracellular localization of mcl-1 (Aim IIIA). We will also determine how expression of the mcl-1 protein relates to hematopoietic cell lineage, maturation stage, and proliferation status (Aim IIIB). Finally, using electroporation, we will test for effects of mcl-1 on cell viability or mitochondrial function (Aim IIIC). It will be interesting to compare mcl-1 to bcl-2, which localizes to mitochondria, is expressed in immature cells of the lymphoid lineage, and can block apoptosis. mcl-1, bcl-2, and a related viral gene BHRF-1, may define a family of genes different from other known families including oncogenes. The studies proposed here should yield information basic to elucidating the function of mcl-1; they may also advance us towards an integrated understanding of this emerging gene family.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA057359-03
Application #
2098094
Study Section
Pathology B Study Section (PTHB)
Project Start
1992-06-01
Project End
1995-05-31
Budget Start
1994-06-01
Budget End
1995-05-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Gui, Jingang; Hu, Zhuting; Tsai, Ching-Yi et al. (2015) MCL1 enhances the survival of CD8+ memory T Cells after viral infection. J Virol 89:2405-14
Nifoussi, Shanna K; Ratcliffe, Nora R; Ornstein, Deborah L et al. (2014) Inhibition of protein phosphatase 2A (PP2A) prevents Mcl-1 protein dephosphorylation at the Thr-163/Ser-159 phosphodegron, dramatically reducing expression in Mcl-1-amplified lymphoma cells. J Biol Chem 289:21950-9
Huang, Li-Hao; Gui, Jingang; Artinger, Erika et al. (2013) Acat1 gene ablation in mice increases hematopoietic progenitor cell proliferation in bone marrow and causes leukocytosis. Arterioscler Thromb Vasc Biol 33:2081-7
Nifoussi, Shanna K; Vrana, Julie A; Domina, Aaron M et al. (2012) Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancer. PLoS One 7:e47060
Gui, Jingang; Morales, Amanda J; Maxey, Sophie E et al. (2011) MCL1 increases primitive thymocyte viability in female mice and promotes thymic expansion into adulthood. Int Immunol 23:647-59
De Biasio, Alfredo; Vrana, Julie A; Zhou, Ping et al. (2007) N-terminal truncation of antiapoptotic MCL1, but not G2/M-induced phosphorylation, is associated with stabilization and abundant expression in tumor cells. J Biol Chem 282:23919-36
Kobayashi, Shogo; Lee, Sun-Hee; Meng, Xue W et al. (2007) Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1. J Biol Chem 282:18407-17
Marriott, Helen M; Bingle, Colin D; Read, Robert C et al. (2005) Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance. J Clin Invest 115:359-68
Domina, Aaron M; Vrana, Julie A; Gregory, Mark A et al. (2004) MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol. Oncogene 23:5301-15
Michels, Jorg; O'Neill, Jason W; Dallman, Claire L et al. (2004) Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage. Oncogene 23:4818-27

Showing the most recent 10 out of 22 publications